Susan J. Knox
Corporate Officer/Principal at Stanford University
Profile
Susan J.
Knox is the founder of EpicentRx, Inc. She is currently an Associate Professor at Stanford University.
Previously, she worked as a Consultant at InterWest Partners LLC.
Dr. Knox holds a doctorate degree from Stanford University and the University of California, Davis, and an undergraduate degree from the University of California, Berkeley.
Susan J. Knox active positions
Companies | Position | Start |
---|---|---|
Stanford University | Corporate Officer/Principal | - |
Former positions of Susan J. Knox
Companies | Position | End |
---|---|---|
EpicentRx, Inc.
EpicentRx, Inc. Pharmaceuticals: MajorHealth Technology EpicentRx, Inc. develops compounds sourced and adapted from the aerospace industry for treating cancer. Its technology includes chemical platform, RRx-001 overview, rons potential, epigenetics, collaboration and immunotherapy. The company was founded by Susan J. Knox and Mark Bednarski and is headquartered in Mountain View, CA. | Founder | - |
InterWest Partners LLC
InterWest Partners LLC Investment ManagersFinance InterWest Partners LLC (InterWest Partners) is a venture capital firm founded in 1979 by Wally Hawley, Scott Hedrick and Gene Barth. The firm is headquartered in San Francisco, California. | Consultant / Advisor | - |
Training of Susan J. Knox
Stanford University | Doctorate Degree |
University of California, Berkeley | Undergraduate Degree |
University of California, Davis | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
InterWest Partners LLC
InterWest Partners LLC Investment ManagersFinance InterWest Partners LLC (InterWest Partners) is a venture capital firm founded in 1979 by Wally Hawley, Scott Hedrick and Gene Barth. The firm is headquartered in San Francisco, California. | Finance |
EpicentRx, Inc.
EpicentRx, Inc. Pharmaceuticals: MajorHealth Technology EpicentRx, Inc. develops compounds sourced and adapted from the aerospace industry for treating cancer. Its technology includes chemical platform, RRx-001 overview, rons potential, epigenetics, collaboration and immunotherapy. The company was founded by Susan J. Knox and Mark Bednarski and is headquartered in Mountain View, CA. | Health Technology |
- Stock Market
- Insiders
- Susan J. Knox